Which is the proper reference tissue for measuring the change in FDG PET metabolic volume of cardiac sarcoidosis before and after steroid therapy?

BACKGROUND: Cardiac sarcoidosis (CS) is a rare but potentially life-threatening disease that causes conduction disturbance, systolic dysfunction, and, most notably, sudden cardiac death. (18)F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) plays important roles no...

Descripción completa

Detalles Bibliográficos
Autores principales: Furuya, Sho, Manabe, Osamu, Ohira, Hiroshi, Hirata, Kenji, Aikawa, Tadao, Naya, Masanao, Tsujino, Ichizo, Koyanagawa, Kazuhiro, Anzai, Toshihisa, Oyama-Manabe, Noriko, Shiga, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173675/
https://www.ncbi.nlm.nih.gov/pubmed/30291527
http://dx.doi.org/10.1186/s13550-018-0447-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173675/
https://www.ncbi.nlm.nih.gov/pubmed/30291527
http://dx.doi.org/10.1186/s13550-018-0447-8

Ejemplares similares